Phase 1 Trial Validates Anti-PD-L1 Antibody for Alzheimer’s

Summary: Researchers announced the successful completion of a Phase 1b clinical trial for a novel immunotherapy for Alzheimer’s disease. The trial evaluated IBC-Ab002, a humanized anti-PD-L1 monoclonal antibody specifically engineered…

COVID-19 mRNA vaccines could unlock the next revolution in cancer treatment – new research

The COVID-19 mRNA-based vaccines that saved 2.5 million lives globally during the pandemic could help spark the immune system to fight cancer. This is the surprising takeaway of a new…

Focused sound energy holds promise for treating cancer, Alzheimer’s and other diseases

Sound waves at frequencies above the threshold for human hearing are routinely used in medical care. Also known as ultrasound, these sound waves can help clinicians diagnose and monitor disease,…

Immunotherapy Shows Promise as Alzheimer’s Treatment

Summary: Researchers unveiled a novel approach to combat Alzheimer’s disease by activating microglia, the brain’s immune cells, to devour amyloid beta plaques, a hallmark of the condition. This study highlights…